Cure51
Paris
About Cure51
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.3M
- Funding stage: Seed
- Last round: Seed (Mar 2024)
- Website: cure51.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Database, Software
Social Profiles
Canonical: https://fsome.com/organization/cure51-16198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.